P‐tau217 testing impact on intended management of patients presenting with cognitive impairment: A randomized clinical utility study

作者
Samantha C. Burnham,Haoyan B Hu,Yifeng Tang,Anthony N. Sireci,Michael J. Pontecorvo,Paul Ernest Schulz,Rosemary D. Laird,Curtis P. Schreiber,Rose C Beck
出处
期刊:Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring [Elsevier BV]
卷期号:17 (4): e70201-e70201 被引量:2
标识
DOI:10.1002/dad2.70201
摘要

INTRODUCTION: Plasma biomarkers are minimally invasive tool for identifying Alzheimer's disease pathology. However, evaluation of their clinical utility remains limited. METHODS: = 218) arms. RESULTS: Change in working diagnosis was observed for 70.5% of patients with a t-tau217 result (positive or negative) inconsistent with baseline working diagnosis compared to 2.3% with a result consistent with baseline working diagnosis and 15.6% of untested patients. When the result was consistent with baseline working diagnosis, a significant 15.7% increase in diagnostic confidence was observed compared to 1.7% in untested patients and 5.0% when the result was inconsistent with baseline working diagnosis. DISCUSSION: P-tau217 testing changed health care providers' intended management and working diagnosis and increased confidence in the diagnosis. Highlights: Evaluation of the clinical utility of plasma tau phosphorylated at position 217 (p-tau217) for identifying Alzheimer's disease pathology has been limited.In this study, the impact of p-tau testing on health care providers' diagnostic thinking in patients under evaluation for cognitive impairment was assessed.When the result was inconsistent with the working diagnosis, a change in the working diagnosis was observed in 70.5% of tested patients.When the result was consistent, diagnostic confidence increased by 15.7%.P-tau217 testing demonstrated clinical utility by changing the working diagnosis, increasing diagnostic confidence, and altering intended patient management.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
redmouse完成签到,获得积分10
刚刚
木木完成签到 ,获得积分10
刚刚
1秒前
1秒前
2秒前
2秒前
kailanshi发布了新的文献求助10
2秒前
lilili的应助被科研通管家采纳,获得10
2秒前
3秒前
英姑的应助被科研通管家采纳,获得10
3秒前
Hello的应助被科研通管家采纳,获得10
3秒前
jin的应助被科研通管家采纳,获得20
3秒前
3秒前
天天快乐的应助被科研通管家采纳,获得10
3秒前
3秒前
李健的应助被科研通管家采纳,获得10
3秒前
ccq的应助被科研通管家采纳,获得10
3秒前
wanci的应助被科研通管家采纳,获得10
3秒前
lilili的应助被科研通管家采纳,获得10
4秒前
研友_VZG7GZ的应助被科研通管家采纳,获得10
4秒前
4秒前
丘比特的应助被科研通管家采纳,获得10
4秒前
4秒前
xing_xing的应助被科研通管家采纳,获得20
4秒前
大个的应助被科研通管家采纳,获得10
4秒前
上官若男的应助被风中的竺采纳,获得10
4秒前
斯文败类的应助被科研通管家采纳,获得10
4秒前
英姑的应助被科研通管家采纳,获得10
4秒前
华仔的应助被科研通管家采纳,获得10
4秒前
skychen发布了新的文献求助10
5秒前
5秒前
沉吟发布了新的文献求助10
5秒前
lilili的应助被科研通管家采纳,获得10
5秒前
kk发布了新的文献求助10
5秒前
xing_xing的应助被科研通管家采纳,获得20
5秒前
Subwaid的应助被执着的飞荷采纳,获得10
5秒前
大模型的应助被科研通管家采纳,获得10
5秒前
Lucas的应助被科研通管家采纳,获得10
5秒前
JeanetteJin发布了新的文献求助10
5秒前
5秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
plantTFDB 508
高分子基功能界面水蒸发材料与应用研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8177654
求助须知:如何正确求助?哪些是违规求助? 9568503
关于积分的说明 21799551
捐赠科研通 7772253
什么是DOI,文献DOI怎么找? 3432428
关于科研通互助平台的介绍 2556594
邀请新用户注册赠送积分活动 2478011